Upgrade to SI Premium - Free Trial

JPMorgan Reinstates Bristol-Myers Squibb Co. (BMY) at Overweight

May 3, 2019 6:45 AM
JPMorgan analyst Chris Schott reinstates coverage on Bristol-Myers Squibb Co. (NYSE: BMY) with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage